Bobbi Jo Brockmann

CIK: 0001517536

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ICCC

IMMUCELL CORP /DE/

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

ICCC
IMMUCELL CORP /DE/
Jan 27, 2026
Award(A)
Stock Options (right to buy)
Direct
100K shares-
ICCC
IMMUCELL CORP /DE/
Apr 16, 2025
Award(A)
Incentive Stock Options (Right to buy)
Direct
5K shares-

		Type	Shares	Price		Ownership
Jan 27, 2026	ICCC IMMUCELL CORP /DE/	Award(A) Stock Options (right to buy)	100,000	-	-	Direct
Apr 16, 2025	ICCC IMMUCELL CORP /DE/	Award(A) Incentive Stock Options (Right to buy)	5,000	-	-	Direct

1-2 of 2 transactions

About Brockmann Bobbi Jo

Brockmann Bobbi Jo (SEC CIK 0001517536) files insider reports with the SEC as VP of Sales and Marketing of IMMUCELL CORP /DE/ (ICCC).

Signal8 holds 2 ownership filings by Brockmann Bobbi Jo, all Form 4s, filed between Jan 29, 2026 and Apr 14, 2026. Those filings report 2 transactions, from Apr 16, 2025 to Jan 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Brockmann Bobbi Jo's filings is in PORTLAND, ME.

Recent filings by Brockmann Bobbi Jo

Jan 27, 2026: Grant or award of ICCC derivative securities (Form 4, code A).
Apr 16, 2025: Grant or award of ICCC derivative securities (Form 4, code A).

Other insiders filing for IMMUCELL CORP /DE/ (ICCC)

te Boekhorst Paul Francis Olivier, President and CEO
DiMarco Anthony, Director
Guillemette Gilles, Director
Turner Kathy V, Director
Tomsche David Scott, Director
Basse Gloria F, Director

How to read Form 4 transaction codes